The cooperation encompasses the fast-growing healthcare market of India, thus granting Indian healthcare professionals improved access to DocCheck’s service range.
D2L Pharma Research Solutions is a privately held, Bangalore headquartered global healthcare service provider with focus on Market Research, Clinical Research, Business Intelligence and Analytics, Pharma Product Development and other related services.
First and foremost, Dr. Frank Antwerpes, CEO of DocCheck, identifies Indian healthcare professionals as profiteers of the cooperation: “With the help of our new partner D2L, we are happy to provide the Indian healthcare community with all the benefits of our service range.”
“As a practicing physician I always believed that connecting to the external experts was the best way to learn newer and better practices.”, states Dr. Sashi Kiran, Chairman and Managing Director (CMD) of D2L Pharma Research Solutions. “The partnership with DocCheck provides for shared best practices without barriers. I am very excited to bring this service to India”.
The cooperation encompasses the fields of market research, industry services and community management in India. This will extend the availability of DocCheck’s services to additional 2,140,000 healthcare professionals (Source: WHO-Statistics 2011).
DocCheck Medical Services
Its over 840,000 users make DocCheck Europe’s largest internet community for healthcare professionals and provide for coverage of a large majority within the healthcare market. Almost every other doctor or pharmacist in Germany is a DocCheck member.
DocCheck offers its members a wide range of content and services related to healthcare. Furthermore, the DocCheck login grants access to doctors-only areas of more than 2,500 medical websites. DocCheck’s most important business models imply eMarketing and eCommerce. A steadily growing number of publishers avail themselves of the opportunity to offer paid content via the DocCheck platform.